635713-68-7 Usage
General Description
2'',3''-dihydro-2''-oxospiro-[piperidine-4,4''(1H'')-quinazoline is a chemical compound with a complex and specialized structure. It contains a spiro ring system made up of a piperidine and quinazoline ring, with a ketone group on the 2'' position. 2'',3''-DIHYDRO-2''-OXOSPIRO-[PIPERIDINE-4,4''(1H'')-QUINAZOLINE may have potential pharmaceutical applications due to the presence of the quinazoline ring, which is found in various bioactive compounds. The spiro ring system and the ketone group also contribute to the unique properties of this chemical, making it an intriguing candidate for further study and possibly for the development of new drugs.
Check Digit Verification of cas no
The CAS Registry Mumber 635713-68-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,3,5,7,1 and 3 respectively; the second part has 2 digits, 6 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 635713-68:
(8*6)+(7*3)+(6*5)+(5*7)+(4*1)+(3*3)+(2*6)+(1*8)=167
167 % 10 = 7
So 635713-68-7 is a valid CAS Registry Number.
635713-68-7Relevant articles and documents
Design and synthesis of potent antagonists containing rigid spirocyclic privileged structures for the CGRP receptor
Chaturvedula, Prasad V.,Pin, Sokhom,Tholady, George,Conway, Charlie M.,MacOr, John E.,Dubowchik, Gene M.
, p. 4719 - 4722 (2012/08/13)
We report the synthesis of rigid spirocyclic systems as conformationally constrained variants of the Ala-Phe-NH2 dipeptide amide C-terminus of the calcitonin gene-related peptide (CGRP). CGRP receptor antagonists containing these moieties displ
Novel therapeutic agents for the treatment of migraine
-
Page/Page column 19, (2010/02/14)
The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors (“CGRP-receptor”), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their u
